Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Comcast
CMCSA
$90B
| $8.46M | 0.01% |
151,283
-1,197
| -0.8% | -$69.8K |
|
352
Cactus
WHD
$5.43B
| $8.19M | 0.01% |
216,989
+12,906
| +6% | +$466K |
|
|
MDC
353
DELISTED
M.D.C. Holdings, Inc.
MDC
| $8.17M | 0.01% |
174,937
+3,258
| +2% | +$165K |
|
354
Prologis
PLD
$133B
| $8M | 0.01% |
63,740
+773
| +1% | +$100K |
|
|
FBGX
355
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
| $7.71M | ﹤0.01% |
10,911
-2,092
| -16% | -$1.57M |
|
356
Pitney Bowes
PBI
$2.47B
| $7.56M | ﹤0.01% |
+1,049,000
| New | +$8.21M |
|
357
Independent Bank
INDB
$4B
| $7.22M | ﹤0.01% |
94,774
-6,907
| -7% | -$506K |
|
358
Ichor Holdings
ICHR
$2.46B
| $7.19M | ﹤0.01% |
+175,000
| New | +$7.99M |
|
|
SPR
359
DELISTED
Spirit AeroSystems
SPR
| $6.93M | ﹤0.01% |
156,828
+21,495
| +16% | +$900K |
|
|
GHL
360
DELISTED
Greenhill & Co., Inc.
GHL
| $6.77M | ﹤0.01% |
463,337
-10,825
| -2% | -$161K |
|
361
Neurocrine Biosciences
NBIX
$16.7B
| $6.64M | ﹤0.01% |
69,194
+7,545
| +12% | +$713K |
|
|
ANSS
362
DELISTED
Ansys
ANSS
| $6.62M | ﹤0.01% |
19,456
+15,272
| +365% | +$5.52M |
|
363
PTC Therapeutics
PTCT
$6.01B
| $6.55M | ﹤0.01% |
176,156
+15,671
| +10% | +$644K |
|
364
Factset
FDS
$10.1B
| $6.48M | ﹤0.01% |
16,403
+6,943
| +73% | +$2.52M |
|
365
Hexcel
HXL
$7.71B
| $6.37M | ﹤0.01% |
107,191
+12,475
| +13% | +$720K |
|
366
Morningstar
MORN
$7.51B
| $6.31M | ﹤0.01% |
24,362
| – | – |
|
367
iShares Expanded Tech-Software Sector ETF
IGV
$14.5B
| $6.31M | ﹤0.01% |
79,000
+1,985
| +3% | +$162K |
|
368
Simmons First National
SFNC
$3.42B
| $6.3M | ﹤0.01% |
213,000
| – | – |
|
|
PCH
369
DELISTED
PotlatchDeltic
PCH
| $6.26M | ﹤0.01% |
121,435
-32,790
| -21% | -$1.71M |
|
370
LivePerson
LPSN
$27.4M
| $6.21M | ﹤0.01% |
7,019
-661
| -9% | -$624K |
|
371
Atlantic Union Bankshares
AUB
$5.97B
| $6.17M | ﹤0.01% |
167,289
| – | – |
|
372
Xylem
XYL
$28.5B
| $6.13M | ﹤0.01% |
49,576
+1,290
| +3% | +$166K |
|
373
Tetra Tech
TTEK
$8.98B
| $6.1M | ﹤0.01% |
204,160
+23,135
| +13% | +$635K |
|
374
Evercore
EVR
$12B
| $6.06M | ﹤0.01% |
45,335
-2,651
| -6% | -$360K |
|
375
Associated Banc-Corp
ASB
$5.88B
| $6.04M | ﹤0.01% |
282,000
| – | – |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.